SlidesetTuberculosis2nd Conference on Innovations in Tuberculosis 2025Abstract #4 - Diagnostic Accuracy of Xpert MTB/RIF Ultra on Nasopharyngeal Swabs in Adults With Presumptive TB in a High-Burden Setting - Robinah NakawundeView Slideset
SlidesetTuberculosis2nd Conference on Innovations in Tuberculosis 2025Abstract #24 - Optimizing the Implementation and Scale-Up of the WHO Treatment- Decision Algorithms for Children with Pulmonary Tuberculosis in Sub-Saharan Africa - Fatuma Said MsafiriView Slideset
SlidesetTuberculosis2nd Conference on Innovations in Tuberculosis 2025Abstract #39 - Use of Artificial Intelligence (AI)-Driven Technology to Drive TB Case Finding: An Eye Opening Experience From Akwa Ibom State, Nigeria - Adekola AdekunleView Slideset
Slideset2nd Conference on Innovations in Tuberculosis 2025Abstract #1 - Development and Internal Evaluation of an AI-Enabled Cough Sound Analysis Model for Tuberculosis Screening in a High-Burden Setting: A Prospective Cross-Sectional Study - Mary Kagujje View Slideset
Video1st International Workshop On Long Acting Anti-Infectives (LAAI) 2025Long-Acting Injectable Formulation of Ivermectin as a New Vector Control Tool to Reduce Malaria Transmission - Quiterie Savary de BeauregardView Video
Slideset1st International Workshop On Long Acting Anti-Infectives (LAAI) 2025Long-Acting Injectable Formulation of Ivermectin as a New Vector Control Tool to Reduce Malaria Transmission - Quiterie Savary de BeauregardView Slideset
VideoViral Hepatitis and Liver Disease1st International Workshop On Long Acting Anti-Infectives (LAAI) 2025Abstract LB #4 Global Perspectives of People Living with Hepatitis B on Long-Acting Antivirals: Survey Results - Yasmin IbrahimView Video
SlidesetViral Hepatitis and Liver Disease1st International Workshop On Long Acting Anti-Infectives (LAAI) 2025Abstract LB #4 Global Perspectives of People Living with Hepatitis B on Long-Acting Antivirals: Survey Results - Yasmin IbrahimView Slideset
VideoHIVTuberculosisViral Hepatitis and Liver Disease1st International Workshop On Long Acting Anti-Infectives (LAAI) 2025Abstract #9 LAPaL: Your Free Digital Compass in the Evolving Long-Acting Therapeutics Landscape - Lobna GaayebView Video
SlidesetHIVTuberculosisViral Hepatitis and Liver Disease1st International Workshop On Long Acting Anti-Infectives (LAAI) 2025Abstract #9 LAPaL: Your Free Digital Compass in the Evolving Long-Acting Therapeutics Landscape - Lobna GaayebView Slideset
VideoHIV1st International Workshop On Long Acting Anti-Infectives (LAAI) 2025Abstract #8 VH3810109 (N6LS) Efficacy and Safety in Adults Who Are Virologically Suppressed: The EMBRACE Study - Rulan GrieselView Video
SlidesetHIV1st International Workshop On Long Acting Anti-Infectives (LAAI) 2025Abstract #8 VH3810109 (N6LS) Efficacy and Safety in Adults Who Are Virologically Suppressed: The EMBRACE Study - Rulan GrieselView Slideset
